VSee Health, Inc. projects its annual revenue will approximately double by 2027, a target set against the backdrop of a recent Nasdaq delisting. In a letter to shareholders dated October 22, 2026, Chairman and Chief Executive Officer Dr. Imoigele Aisiku outlined a strategic shift toward the company's hospital-focused telehealth business, iDoc, as the primary driver for future growth and profitability.
The delisting from Nasdaq has prompted management to concentrate resources on expanding hospital relationships and activating services. Aisiku noted that the company previously reported growth into 58 hospitals. While the letter states that revenue from continuing operations grew in the first half of 2026 compared with the same period last year, it does not specify the exact figures for that increase. The company is currently in the initial stages of deploying these services, with the aim of building a larger base for utilization as contracts become active.
The 2027 plan relies on several operational improvements to reach the revenue target and achieve a clear path to profitability. Management expects margins to improve as more contracted services are activated and delivery costs are managed. Aisiku indicated that operational efficiencies will be a key factor in driving shareholder value over the next 12 months. The company is also evaluating M&A activities that align with its platform and services, though no specific deals were announced in the letter.
To improve its public market profile, VSee Health is working to move to the OTCQB market. Beyond this immediate step, the company intends to position itself for reinstatement on either Nasdaq or the NYSE once it meets applicable listing requirements and the board determines the timing is appropriate. Management is simultaneously evaluating other avenues to maximize shareholder value, including partnerships, financing alternatives, and other corporate transactions. Each opportunity will be assessed based on its ability to support iDoc's growth.
VSee Health describes itself as a telehealth technology and services company delivering high-acuity virtual care solutions through a scalable, API-driven platform. Its offerings integrate secure video, device data, and EHR connectivity for hospital systems, health networks, and employers across the United States. The letter includes standard forward-looking statement disclaimers, noting that projections are based on current assumptions and subject to risks that may cause actual results to differ materially.